CJMB Overview

Expansion into New Markets: Callan JMB has expanded its compliance-driven logistics platform into the food sampling industry and established a subsidiary in India for temperature-controlled pharmaceutical storage and distribution.

Agreements and Contracts: The company entered a preliminary agreement to install oral drug delivery equipment in Texas and extended its emergency preparedness contract with the City of Chicago through June 2026, increasing total contract value to $9.1 million.

Technology Upgrades: Callan JMB upgraded its Sentry Monitoring System to version 4.0, enhancing temperature monitoring capabilities for healthcare facilities and emergency management agencies.

Financial Performance: For Q3 2025, the company reported revenues of $1.4 million, a decrease from the previous year, with a net loss of $2.7 million, attributed to seasonal declines in emergency preparedness services.

Expansion into Food Sampling: Callan JMB Inc. has announced the expansion of its reclamation operations into the food sampling industry through a partnership with Keychain, an AI-enabled platform for consumer packaged goods.

Growth Strategy: This initiative is part of Callan JMB's strategy to enhance its compliance-driven model in high-growth markets, aiming to streamline compliance and sustainability in food distribution.

CEO's Insights: CEO Wayne Williams emphasized the importance of their compliance infrastructure in ensuring safety and accountability, which is crucial for maintaining consumer trust in both pharmaceuticals and food sampling.

Recent Financial Performance: In August 2025, Callan JMB reported a second-quarter loss of 31 cents per share, with revenue falling short of expectations at $1.666 million compared to $1.986 million in the previous year.